LEVYRA editorial standards: sources, review and quality

Who is responsible for the content?

The public knowledge content is created and maintained jointly by the LEVYRA editorial team. The editorial work is shared between several people. Information on the legal provider and the legally required responsibilities can be found separately in the legal notice (Impressum, in German).

LEVYRA grew out of a personal GLP-1 journey. This experience shapes which questions are covered: everyday life with the therapy, documentation, weight trends and looking beyond the scale. Personal experience is not evidence, though: medical statements are always based on the sources described below.

Meet the work areas behind LEVYRA →

Medical review: planned, not yet done

At present the knowledge articles are not reviewed by a physician. Every article says so. An external review by qualified professionals is the goal. Once an article has actually been reviewed, it will show the reviewer’s name, qualification and the review date. Until then there is no seal and no expert name.

Which sources take priority?

Which source is decisive depends on the question. The following types of sources are weighted differently depending on the statement:

1. Official product informationAuthorisation and product information from the European Medicines Agency (EMA), complemented by the German BfArM. They are especially important for approved use, dosing and safety information.
2. Guidelines and medical societiesFor example the German S3 guideline on obesity in the AWMF register, the German Obesity Society (DAG) and the German Diabetes Society (DDG).
3. Studies in peer-reviewed journalsOriginal publications, for example in the New England Journal of Medicine or Diabetes Care, found via PubMed. Results are described with the population studied, duration and comparison.
4. Independent health informationFor example gesundheitsinformation.de (IQWiG) and the German federal health portal, especially for plain-language context.
5. Manufacturer informationUsed as a complement for practical handling instructions; promotional manufacturer claims are not treated as independent evidence of effectiveness.

Linked organisations have no connection to LEVYRA. An overview of important bodies is available under medical sources (in German).

How an article is made

1. Clarify the questionWhat do people on a GLP-1 therapy really want to know, and what of it can be backed up?
2. Research primary sourcesSuitable original sources depending on the question, such as product information, a guideline or a study.
3. Write a draftClear, without promises of cures, including limits and risks. AI may help.
4. Check key medical statementsEspecially figures, doses, time windows and study results against suitable original sources.
5. Approve and publishWith numbered sources, date and review status on the article.
6. Keep it currentNew product information, guidelines or reader feedback lead to revisions.

How does LEVYRA use AI?

Yes, the editorial team uses AI tools, for example for outlines, wording and first drafts. Editorial principles apply:

• AI is not a source. Medical statements, figures and study results come from the cited sources, not from an AI model.
• Checking against sources is key. Key medical statements, especially figures and safety information, are meant to be checked against suitable sources before publication. This does not constitute a medical review.
• Responsibility stays human. The editorial team, not the tool, is responsible for content and accuracy.

What do the dates mean?

Published

Date of first publication on LEVYRA.

Last updated

Date of the most recent editorial revision. The date alone does not guarantee a complete reassessment of all sources.

Reasons for updates

Changed product information, new guidelines or relevant studies, and feedback from readers.

The current original information of the linked institutions always takes precedence.

Found an error? Let us know.

If you notice an error, outdated information or misleading wording in an article, please write to impressum@levyra.de. Ideally name the article and the passage concerned, with a source if possible. You can write in English or German.

Justified feedback is checked and corrected, and the article’s update date is adjusted. We cannot answer individual medical questions by email; they belong with a doctor or pharmacist.

Independent and ad-free

LEVYRA is free and shows no ads. Running and developing LEVYRA can be supported voluntarily; support has no influence on topics or content and comes with nothing in return. Recommendations of external offers, such as a community, are labelled as external recommendations.

Information, not advice

LEVYRA Knowledge provides general information. It does not replace a diagnosis, an individual benefit-risk assessment, a dosing decision or any other medical advice. Relationships in time, including in your own data, are not automatically presented as cause and effect. More details: medical disclaimer (in German).